It also shows that co-activation of ALDO and RA signalling results in a stronger anti-proliferative effect compared to activation of each alone, suggesting a co-operative crosstalk of the MR and RAR signalling pathways to inhibit breast cancer growth. The gene discussed is NR3C2; the disease is breast carcinoma.